http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10429288-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15d42f684941d5b0617ca7764ebdff07
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2015-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2001-4083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10351
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N15-042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-4077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-405
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N1-40
filingDate 2016-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69aea732fb8217c13e2e348c40630706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eaa02dabef395d93d407153cc01b346
publicationDate 2019-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-10429288-B2
titleOfInvention Analytical ultracentrifugation for characterization of recombinant viral particles
abstract Provided herein are methods to characterize preparations of recombinant viral particles using analytical ultracentrifugation. Recombinant viral particles include recombinant adeno-associated viral particles, recombinant adenoviral particles, recombinant lentiviral particles and recombinant herpes simplex virus particles. Variant species of recombinant viral particles including empty capsids and recombinant viral particles with variant genomes (e.g., truncated genomes, aggregates, recombinants) can be identified and quantitated. The methods can be used to characterize preparations of recombinant viral particles regardless of the sequence of the recombinant viral genome or the serotype of the recombinant viral capsid.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022099547-A1
priorityDate 2015-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8137948-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009017542-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6989264-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010148143-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439530

Total number of triples: 33.